Will Pappenheimer website
The researchers at Virta-Flaneurazine labs will be entering a wider human test phase VF betaAR, November 14 at BETA Spaces 2010 in Bushwick, Brooklyn (NY). The drug tests will be part of an art program Bushwick AR Intervention. A new variant of Virta-Flaneurazine, VF betaAR, has been successfully developed which is produced from the skin secretions of bio- engineered and programmed hybrid Bufo toads. When areas of these toads are touched, the resulting reaction causes a wandering viewer to see things appearing from virtual worlds and other sources on the Internet. This perception can be simultaneously viewed on an iPhone or Android device using Layars or other augmented reality software. Though the parameters of the effects are somewhat limited at this point, this appears to be a very important step towards an integrated and compelling conscious experience.
Test participants with iPhone or Androids and the Layars App will be able to visit a large-scale bufo hybrid toad at Maria Hernandez Park and after touching it, experience the effects of VF betaAR while wandering through Bushwick to a network of parks each generating a particular vision in the “ar intervention 1” “VF betaAR” Layar. The location of these experiences will be mapped for participants as the the date of the event approaches.
from the clinical team leaders: Will Pappenheimer and John Craig Freeman
“Black Bats Red Bats” visualization